- Abbott Laboratories (ABT -0.6%) acquires privately-held Roseville, MN-based Tendyne Holdings for $250M plus regulatory-based milestones. Abbott will pay $225M upfront to acquire the equity in Tendyne that it does not already own.
- Tendyne is developing a replacement tissue valve for the treatment of advanced mitral regurgitation that can be placed into the heart without the use of cardio-pulmonary bypass.
Abbott buys heart valve maker for $250M
Recommended For You
About ABT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ABT | - | - |
| Abbott Laboratories | ||